Pharmacology of heparin and related drugs: An update

J Hogwood, B Mulloy, R Lever, E Gray, CP Page - Pharmacological reviews, 2023 - ASPET
Heparin has been used extensively as an antithrombotic and anticoagulant for close to 100
years. This anticoagulant activity is attributed mainly to the pentasaccharide sequence …

Pharmacology of heparin and related drugs

B Mulloy, J Hogwood, E Gray, R Lever, CP Page - Pharmacological reviews, 2016 - ASPET
Heparin has been recognized as a valuable anticoagulant and antithrombotic for several
decades and is still widely used in clinical practice for a variety of indications. The …

Cardiovascular complications of pregnancy

MC Gongora, NK Wenger - International journal of molecular sciences, 2015 - mdpi.com
Pregnancy causes significant metabolic and hemodynamic changes in a woman's
physiology to allow for fetal growth. The inability to adapt to these changes might result in …

The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review

J Zhai, Z Li, Y Zhou, X Yang - Journal of reproductive immunology, 2022 - Elsevier
In a normal pregnancy, maternal circulatory system presents a hypercoagulable state due to
the effect of hormone secretion. Even minor variations in fibrinolytic system could lead to …

Heparin: an essential drug for modern medicine

C Hao, H Xu, L Yu, L Zhang - … in molecular biology and translational science, 2019 - Elsevier
Heparin is a life-saving drug, which belongs to few clinically used drugs without defined
molecular structures in modern medicine. Heparin is the mostly negatively charged …

Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period

P Middleton, E Shepherd… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Venous thromboembolism (VTE), although rare, is a major cause of maternal
mortality and morbidity. Some women are at increased risk of VTE during pregnancy and the …

Inherited thrombophilias and adverse pregnancy outcomes: a review of screening patterns and recommendations

WB Davenport, WH Kutteh - Obstetrics and Gynecology …, 2014 - obgyn.theclinics.com
Three decades ago, antiphospholipid antibodies (aPL) were proposed to have a causal
association with recurrent pregnancy loss (RPL), suspected because of placental clots that …

Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism as a conjoint regulator of coagulation, fibrinolytic, and RAAS pathway in infertility and …

S Thakur, V Sharma, D Kaur… - Journal of the Renin …, 2022 - journals.sagepub.com
Despite the increase in assisted reproductive technologies, the high rates of infertility and
pregnancy complications are a major concern to infertility specialists worldwide. Infertility …

Not Just Anticoagulation—New and Old Applications of Heparin

L Zang, H Zhu, K Wang, Y Liu, F Yu, W Zhao - Molecules, 2022 - mdpi.com
In recent decades, heparin, as the most important anticoagulant drug, has been widely used
in clinical settings to prevent and treat thrombosis in a variety of diseases. However, with in …

Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss

MT Su, SH Lin, YC Chen, PL Kuo - Thrombosis and …, 2013 - thieme-connect.com
A fine balance between coagulation and fibrinolysis is critical in early pregnancy.
Plasminogen activator inhibitor-1 (PAI-1) and angiotensin converting enzyme (ACE) are …